The DOI matches its Crossref record; 283 of the 283 references it cites were found in a registry or an index.
Myeloid Cell-Derived Arginase in Cancer Immune Response
Open accessAbstract
Amino acid metabolism is a critical regulator of the immune response, and its modulating becomes a promising approach in various forms of immunotherapy. Insufficient concentrations of essential amino acids restrict T-cells activation and proliferation. However, only arginases, that degrade L-arginine, as well as enzymes that hydrolyze L-tryptophan are substantially increased in cancer. Two arginase isoforms, ARG1 and ARG2, have been found to be present in tumors and their increased activity usually correlates with more advanced disease and worse clinical prognosis. Nearly all types of myeloid cells were reported to produce arginases and the increased numbers of various populations of myeloid-derived suppressor cells and macrophages correlate with inferior clinical outcomes of cancer patients. Here, we describe the role of arginases produced by myeloid cells in regulating various populations of immune cells, discuss molecular mechanisms of immunoregulatory processes involving L-arginine metabolism and outline therapeutic approaches to mitigate the negative effects of arginases on antitumor immune response. Development of potent arginase inhibitors, with improved pharmacokinetic properties, may lead to the elaboration of novel therapeutic strategies based on targeting immunoregulatory pathways controlled by L-arginine degradation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Robert, C., Schachter, J., Long, G. V., Arance, A., Grob, J. J., Mortier, L., Daud, A., Carlino, M. S., McNeil, C., Lotem, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503093 · Cited by 5,887
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Inflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
Hamid, O., Robert, C., Daud, A., Hodi, F. S., Hwu, W.-J., Kefford, R., Wolchok, J. D., Hersey, P., Joseph, R. W., Weber, J. S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305133 · Cited by 3,392
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046 · cited 3×
“TAMs in lung cancer and melanoma also express more ARG1 than all other cells within tumor combined (178) and have over 20 times higher expression of ARG1 as compared with peritoneal macrophages (184).”
BackgroundArginine metabolism: nitric oxide and beyond
WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Bronte, V., Brandau, S., Chen, S.-H., Colombo, M. P., Frey, A. B., Greten, T. F., Mandruzzato, S., Murray, P. J., Ochoa, A., Ostrand-Rosenberg, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12150 · Cited by 2,751
Macrophages as regulators of tumour immunity and immunotherapy
DeNardo, D. G., & Ruffell, B. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0127-6 · Cited by 2,528
The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation
Wang, R., Dillon, C. P., Shi, L. Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L. L., Fitzgerald, P., Chi, H., Munger, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.021 · Cited by 2,140 · cited 1×
“It has been suggested that the synthesis of polyamines in T-cells is under the direction of Myc, as Mycdeficient T-cells fail to induce ODC and other genes involved in polyamine synthesis, leading to decreased polyamine production (262).”
BackgroundOrecchioni, M., Ghosheh, Y., Pramod, A. B., & Ley, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01084 · Cited by 2,063
Macrophages and metabolism in the tumor microenvironment
Vitale, I., Manic, G., Coussens, L. M., Kroemer, G., & Galluzzi, L. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.001 · Cited by 1,837 · cited 2×
“Additionally, these cells do not form a stable population, but are highly variable both in time and location within the tumor milieu (165, 166).”
BackgroundL-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
Geiger, R., Rieckmann, J. C., Wolf, T., Basso, C., Feng, Y., Fuhrer, T., Kogadeeva, M., Picotti, P., Meissner, F., Mann, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.031 · Cited by 1,775
Myeloid-derived suppressor cells coming of age
Veglia, F., Perego, M., & Gabrilovich, D. (2018) · Nature Immunology · doi:10.1038/s41590-017-0022-x · Cited by 1,767
Cancer immunoediting and resistance to T cell-based immunotherapy
O’Donnell, J. S., Teng, M. W. L., & Smyth, M. J. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0142-8 · Cited by 1,759
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Youn, J.-I., Nagaraj, S., Collazo, M., & Gabrilovich, D. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5791 · Cited by 1,645
Diep, B. A., Gill, S. R., Chang, R. F., Phan, T. H., Chen, J. H., Davidson, M. G., Lin, F., Lin, J., Carleton, H. A., Mongodin, E. F., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68231-7 · Cited by 1,633
Origin and functions of tissue macrophages
Epelman, S., Lavine, K. J., & Randolph, G. J. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.013 · Cited by 1,585 · cited 1×
“Some tissue macrophages develop from embryonic precursors that directly home to peripheral tissues and become a self-renewing population (88).”
BackgroundMacrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite
Hibbs, J. B., Taintor, R. R., & Vavrin, Z. (1987) · Science · doi:10.1126/science.2432665 · Cited by 1,527
Zilionis, R., Engblom, C., Pfirschke, C., Savova, V., Zemmour, D., Saatcioglu, H. D., Krishnan, I., Maroni, G., Meyerovitz, C. V., Kerwin, C. M., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.009 · Cited by 1,475
Huang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., & Chen, S.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1299 · Cited by 1,435
Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?
Rosales, C. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00113 · Cited by 1,334
The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F., Kozma, S. C., & Powell, J. D. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.014 · Cited by 1,284
Rodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0465 · Cited by 1,276
Stuehr, D. J., & Marletta, M. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.22.7738 · Cited by 1,126
Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
Coussens, L. M., Zitvogel, L., & Palucka, A. K. (2013) · Science · doi:10.1126/science.1232227 · Cited by 1,079
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
Munn, D. H., & Mellor, A. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31178 · Cited by 1,078
Zhang, Q.-W., Liu, L., Gong, C.-Y., Shi, H.-S., Zeng, Y.-H., Wang, X.-Z., Zhao, Y.-W., & Wei, Y.-Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050946 · Cited by 1,039
L-arginine availability regulates T-lymphocyte cell-cycle progression.
Rodriguez, P. C., Quiceno, D. G., & Ochoa, A. C. (2007) · Blood · doi:10.1182/blood-2006-06-031856 · Cited by 926
Cassetta, L., Fragkogianni, S., Sims, A. H., Swierczak, A., Forrester, L. M., Zhang, H., Soong, D. Y. H., Cotechini, T., Anur, P., Lin, E. Y., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.02.009 · Cited by 920
Fuel feeds function: energy metabolism and the T-cell response
Fox, C. J., Hammerman, P. S., & Thompson, C. B. (2005) · Nature Reviews Immunology · doi:10.1038/nri1710 · Cited by 853
Zea, A. H., Rodriguez, P. C., Atkins, M. B., Hernandez, C., Signoretti, S., Zabaleta, J., McDermott, D., Quiceno, D., Youmans, A., O'Neill, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4505 · Cited by 851
Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription Factor
Marigo, I., Bosio, E., Solito, S., Mesa, C., Fernandez, A., Dolcetti, L., Ugel, S., Sonda, N., Bicciato, S., Falisi, E., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.010 · Cited by 850
Dendritic Cells: Translating Innate to Adaptive Immunity
Steinman, R. M., & Hemmi, H. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-32636-7_2 · Cited by 844
Dendritic cell subsets in T cell programming: location dictates function
Eisenbarth, S. C. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-018-0088-1 · Cited by 827
Polyamine metabolism and cancer: treatments, challenges and opportunities
Casero, R. A., Murray Stewart, T., & Pegg, A. E. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0050-3 · Cited by 817
Irving, B. A., & Weiss, A. (1991) · Cell · doi:10.1016/0092-8674(91)90314-o · Cited by 805
Zhu, Y., Herndon, J. M., Sojka, D. K., Kim, K.-W., Knolhoff, B. L., Zuo, C., Cullinan, D. R., Luo, J., Bearden, A. R., Lavine, K. J., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.014 · Cited by 801
Hoechst, B., Ormandy, L. A., Ballmaier, M., Lehner, F., Krüger, C., Manns, M. P., Greten, T. F., & Korangy, F. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.020 · Cited by 793 · cited 1×
“Arginaseexpressing MDSCs were also shown to induce Tregs in murine tumor models (153) as well as in cancer patients (154).”
BackgroundmTORC1 couples immune signals and metabolic programming to establish Treg-cell function
Zeng, H., Yang, K., Cloer, C., Neale, G., Vogel, P., & Chi, H. (2013) · Nature · doi:10.1038/nature12297 · Cited by 788
Rodriguez, P. C., Ernstoff, M. S., Hernandez, C., Atkins, M., Zabaleta, J., Sierra, R., & Ochoa, A. C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1921 · Cited by 773
R EGULATION OF E NZYMES OF THE U REA C YCLE AND A RGININE M ETABOLISM
Morris, S. M. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.110801.140547 · Cited by 725
Arginase: an emerging key player in the mammalian immune system
Munder, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00291.x · Cited by 694
Origins of tumor-associated macrophages and neutrophils
Cortez-Retamozo, V., Etzrodt, M., Newton, A., Rauch, P. J., Chudnovskiy, A., Berger, C., Ryan, R. J. H., Iwamoto, Y., Marinelli, B., Gorbatov, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113744109 · Cited by 689
The SLC3 and SLC7 families of amino acid transporters
Fotiadis, D., Kanai, Y., & Palacín, M. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.007 · Cited by 680
Serafini, P., Mgebroff, S., Noonan, K., & Borrello, I. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6621 · Cited by 673
Doedens, A. L., Stockmann, C., Rubinstein, M. P., Liao, D., Zhang, N., DeNardo, D. G., Coussens, L. M., Karin, M., Goldrath, A. W., & Johnson, R. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1439 · Cited by 652
El Kasmi, K. C., Qualls, J. E., Pesce, J. T., Smith, A. M., Thompson, R. W., Henao-Tamayo, M., Basaraba, R. J., König, T., Schleicher, U., Koo, M.-S., et al. (2008) · Nature Immunology · doi:10.1038/ni.1671 · Cited by 646 · cited 2×
“Importantly, some intracellular pathogens induce expression of ARG1 in macrophages that hampers effective immune response (137).”
BackgroundT-cell-antigen recognition and the immunological synapse
Huppa, J. B., & Davis, M. M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1245 · Cited by 643
Bunt, S. K., Yang, L., Sinha, P., Clements, V. K., Leips, J., & Ostrand-Rosenberg, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2354 · Cited by 633
Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-10
Lang, R., Patel, D., Morris, J. J., Rutschman, R. L., & Murray, P. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2253 · Cited by 613
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
Rodriguez, P. C., Hernandez, C. P., Quiceno, D., Dubinett, S. M., Zabaleta, J., Ochoa, J. B., Gilbert, J., & Ochoa, A. C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050715 · Cited by 609
Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells
Marigo, I., Dolcetti, L., Serafini, P., Zanovello, P., & Bronte, V. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00602.x · Cited by 608
Comparative properties of arginases
Jenkinson, C. P., Grody, W. W., & Cederbaum, S. D. (1996) · Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology · doi:10.1016/0305-0491(95)02138-8 · Cited by 606
Sullivan, M. R., Danai, L. V., Lewis, C. A., Chan, S. H., Gui, D. Y., Kunchok, T., Dennstedt, E. A., Vander Heiden, M. G., & Muir, A. (2019) · eLife · doi:10.7554/elife.44235 · Cited by 588 · cited 2×
“While the concentration of L-arg substantially decreases in cancer, the concentration of L-ornithine increases (59, 75, 257).”
BackgroundGabitass, R. F., Annels, N. E., Stocken, D. D., Pandha, H. A., & Middleton, G. W. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1028-0 · Cited by 575
Th1/Th2-Regulated Expression of Arginase Isoforms in Murine Macrophages and Dendritic Cells
Munder, M., Eichmann, K., Morán, J. M., Centeno, F., Soler, G., & Modolell, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3771 · Cited by 561
Tumor Immunology and Tumor Evolution: Intertwined Histories
Galon, J., & Bruni, D. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.018 · Cited by 540
Yurdagul, A., Subramanian, M., Wang, X., Crown, S. B., Ilkayeva, O. R., Darville, L., Kolluru, G. K., Rymond, C. C., Gerlach, B. D., Zheng, Z., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.01.001 · Cited by 525 · cited 1×
“ARG1 was also recently shown to be crucial in efferocytic clearance of apoptotic cells by macrophages (255).”
BackgroundMacrophage plasticity in experimental atherosclerosis
Khallou-Laschet, J., Varthaman, A., Fornasa, G., Compain, C., Gaston, A.-T., Clement, M., Dussiot, M., Levillain, O., Graff-Dubois, S., Nicoletti, A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008852 · Cited by 517
IL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice
Bronte, V., Serafini, P., De Santo, C., Marigo, I., Tosello, V., Mazzoni, A., Segal, D. M., Staib, C., Lowel, M., Sutter, G., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.270 · Cited by 513
Youn, J.-I., Collazo, M., Shalova, I. N., Biswas, S. K., & Gabrilovich, D. I. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0311177 · Cited by 510
Regulation of T Cell Receptor CD3ζ Chain Expression byl-Arginine
Rodriguez, P. C., Zea, A. H., Culotta, K. S., Zabaleta, J., Ochoa, J. B., & Ochoa, A. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110675200 · Cited by 509
STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients
Vasquez-Dunddel, D., Pan, F., Zeng, Q., Gorbounov, M., Albesiano, E., Fu, J., Blosser, R. L., Tam, A. J., Bruno, T., Zhang, H., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci60083 · Cited by 507
Arginase: A Multifaceted Enzyme Important in Health and Disease
Caldwell, R. W., Rodriguez, P. C., Toque, H. A., Narayanan, S. P., & Caldwell, R. B. (2018) · Physiological Reviews · doi:10.1152/physrev.00037.2016 · Cited by 495
l -Arginine Consumption by Macrophages Modulates the Expression of CD3ζ Chain in T Lymphocytes
Rodriguez, P. C., Zea, A. H., DeSalvo, J., Culotta, K. S., Zabaleta, J., Quiceno, D. G., Ochoa, J. B., & Ochoa, A. C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1232 · Cited by 492
Arginase, Prostaglandins, and Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma
Ochoa, A. C., Zea, A. H., Hernandez, C., & Rodriguez, P. C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2197 · Cited by 489
Steggerda, S. M., Bennett, M. K., Chen, J., Emberley, E., Huang, T., Janes, J. R., Li, W., MacKinnon, A. L., Makkouk, A., Marguier, G., et al. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0308-4 · Cited by 476
T cell responses: naïve to memory and everything in between
Pennock, N. D., White, J. T., Cross, E. W., Cheney, E. E., Tamburini, B. A., & Kedl, R. M. (2013) · Advances in Physiology Education · doi:10.1152/advan.00066.2013 · Cited by 461
Neutrophils in cancer: prognostic role and therapeutic strategies
Ocana, A., Nieto-Jiménez, C., Pandiella, A., & Templeton, A. J. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0707-7 · Cited by 459
Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages
Bohn, T., Rapp, S., Luther, N., Klein, M., Bruehl, T.-J., Kojima, N., Aranda Lopez, P., Hahlbrock, J., Muth, S., Endo, S., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0226-8 · Cited by 436
Morris, S. M. (2016) · The Journal of Nutrition · doi:10.3945/jn.115.226621 · Cited by 435 · cited 1×
“Under pathological conditions (bleeding, sepsis, trauma, cancer, or chronic inflammation) endogenous sources of L-arg become insufficient (13).”
BackgroundImmunosuppressive CD71+ erythroid cells compromise neonatal host defence against infection
Elahi, S., Ertelt, J. M., Kinder, J. M., Jiang, T. T., Zhang, X., Xin, L., Chaturvedi, V., Strong, B. S., Qualls, J. E., Steinbrecher, K. A., et al. (2013) · Nature · doi:10.1038/nature12675 · Cited by 420
Suppression of T-cell functions by human granulocyte arginase
Munder, M. (2006) · Blood · doi:10.1182/blood-2006-11-010389 · Cited by 417
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
Garg, A. D., Galluzzi, L., Apetoh, L., Baert, T., Birge, R. B., Bravo-San Pedro, J. M., Breckpot, K., Brough, D., Chaurio, R., Cirone, M., et al. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00588 · Cited by 410
Self-citationAlkali production by oral bacteria and protection against dental caries
Burne, R. A., & Marquis, R. E. (2000) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2000.tb09393.x · Cited by 400
On the Dynamics of TCR:CD3 Complex Cell Surface Expression and Downmodulation
Liu, H., Rhodes, M., Wiest, D. L., & Vignali, D. A. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)00066-2 · Cited by 374
Gundra, U. M., Girgis, N. M., Ruckerl, D., Jenkins, S., Ward, L. N., Kurtz, Z. D., Wiens, K. E., Tang, M. S., Basu-Roy, U., Mansukhani, A., et al. (2014) · Blood · doi:10.1182/blood-2013-08-520619 · Cited by 371
Pan, M., Reid, M. A., Lowman, X. H., Kulkarni, R. P., Tran, T. Q., Liu, X., Yang, Y., Hernandez-Davies, J. E., Rosales, K. K., Li, H., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3410 · Cited by 368
Corraliza, I. M., Soler, G., Eichmann, K., & Modolell, M. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1094 · Cited by 365
Kono, K., Salazar‐Onfray, F., Petersson, M., Hansson, J., Masucci, G., Wasserman, K., Nakazawa, T., Anderson, P., & Kiessling, R. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260620 · Cited by 359
Lee, J., Ryu, H., Ferrante, R. J., Morris, S. M., & Ratan, R. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0735876100 · Cited by 358
Temporal expression of different pathways of 1-arginine metabolism in healing wounds.
Albina, J. E., Mills, C. D., Henry, W. L., & Caldwell, M. D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.10.3877 · Cited by 351
The IL-21 receptor augments Th2 effector function and alternative macrophage activation
Pesce, J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27727 · Cited by 346
CD11b+/Gr-1+ Myeloid Suppressor Cells Cause T Cell Dysfunction after Traumatic Stress
Makarenkova, V. P., Bansal, V., Matta, B. M., Perez, L. A., & Ochoa, J. B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2085 · Cited by 345
Requirement for cyclin D3 in lymphocyte development and T cell leukemias
Sicinska, E., Aifantis, I., Le Cam, L., Swat, W., Borowski, C., Yu, Q., Ferrando, A. A., Levin, S. D., Geng, Y., von Boehmer, H., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00301-5 · Cited by 340
Infectious tolerance via the consumption of essential amino acids and mTOR signaling
Cobbold, S. P., Adams, E., Farquhar, C. A., Nolan, K. F., Howie, D., Lui, K. O., Fairchild, P. J., Mellor, A. L., Ron, D., & Waldmann, H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903919106 · Cited by 336
Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity
Munder, M. (2005) · Blood · doi:10.1182/blood-2004-07-2521 · Cited by 335
Mondanelli, G., Bianchi, R., Pallotta, M. T., Orabona, C., Albini, E., Iacono, A., Belladonna, M. L., Vacca, C., Fallarino, F., Macchiarulo, A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.01.005 · Cited by 333
Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment
Mussai, F., De Santo, C., Abu-Dayyeh, I., Booth, S., Quek, L., McEwen-Smith, R. M., Qureshi, A., Dazzi, F., Vyas, P., & Cerundolo, V. (2013) · Blood · doi:10.1182/blood-2013-01-480129 · Cited by 332
Arginase: an old enzyme with new tricks
Caldwell, R. B., Toque, H. A., Narayanan, S. P., & Caldwell, R. W. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.03.006 · Cited by 332
Arg1 expression defines immunosuppressive subsets of tumor-associated macrophages
Arlauckas, S. P., Garren, S. B., Garris, C. S., Kohler, R. H., Oh, J., Pittet, M. J., & Weissleder, R. (2018) · Theranostics · doi:10.7150/thno.26888 · Cited by 331
Degradation of T Cell Receptor (TCR)–CD3-ζ Complexes after Antigenic Stimulation
Valitutti, S., Müller, S., Salio, M., & Lanzavecchia, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.10.1859 · Cited by 327
Mohammadpour, H., MacDonald, C. R., Qiao, G., Chen, M., Dong, B., Hylander, B. L., McCarthy, P. L., Abrams, S. I., & Repasky, E. A. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129502 · Cited by 320
Czystowska-Kuzmicz, M., Sosnowska, A., Nowis, D., Ramji, K., Szajnik, M., Chlebowska-Tuz, J., Wolinska, E., Gaj, P., Grazul, M., Pilch, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10979-3 · Cited by 312
Self-citationThe Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy
Hornyák, L., Dobos, N., Koncz, G., Karányi, Z., Páll, D., Szabó, Z., Halmos, G., & Székvölgyi, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00151 · Cited by 311
Mechanism of arginine sensing by CASTOR1 upstream of mTORC1
Saxton, R. A., Chantranupong, L., Knockenhauer, K. E., Schwartz, T. U., & Sabatini, D. M. (2016) · Nature · doi:10.1038/nature19079 · Cited by 308
Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells
Raes, G., Van den Bergh, R., De Baetselier, P., & Ghassabeh, G. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.6561 · Cited by 302
Activated macrophages kill tumour cells by releasing arginase
CURRIE, G. A. (1978) · Nature · doi:10.1038/273758a0 · Cited by 301
Macrophages of distinct origins contribute to tumor development in the lung
Loyher, P.-L., Hamon, P., Laviron, M., Meghraoui-Kheddar, A., Goncalves, E., Deng, Z., Torstensson, S., Bercovici, N., Baudesson de Chanville, C., Combadière, B., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180534 · Cited by 298
Plasma Membrane Transporters for Arginine
Closs, E. I., Simon, A., Vékony, N., & Rotmann, A. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.10.2752s · Cited by 297
Chang, C., Liao, J. C., & Kuo, L. (2001) · PubMed · Cited by 294
Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity
Rodriguez, P. C., Ochoa, A. C., & Al-Khami, A. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00093 · Cited by 285
l -Arginine Depletion Blunts Antitumor T-cell Responses by Inducing Myeloid-Derived Suppressor Cells
Fletcher, M., Ramirez, M. E., Sierra, R. A., Raber, P., Thevenot, P., Al-Khami, A. A., Sanchez-Pino, D., Hernandez, C., Wyczechowska, D. D., Ochoa, A. C., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1491 · Cited by 281
Norian, L. A., Rodriguez, P. C., O'Mara, L. A., Zabaleta, J., Ochoa, A. C., Cella, M., & Allen, P. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2826 · Cited by 270
Qie, Y., Yuan, H., von Roemeling, C. A., Chen, Y., Liu, X., Shih, K. D., Knight, J. A., Tun, H. W., Wharen, R. E., Jiang, W., et al. (2016) · Scientific Reports · doi:10.1038/srep26269 · Cited by 260
Human fetal dendritic cells promote prenatal T-cell immune suppression through arginase-2
McGovern, N., Shin, A., Low, G., Low, D., Duan, K., Yao, L. J., Msallam, R., Low, I., Shadan, N. B., Sumatoh, H. R., et al. (2017) · Nature · doi:10.1038/nature22795 · Cited by 256
Thevenot, P. T., Sierra, R. A., Raber, P. L., Al-Khami, A. A., Trillo-Tinoco, J., Zarreii, P., Ochoa, A. C., Cui, Y., Del Valle, L., & Rodriguez, P. C. (2014) · Immunity · doi:10.1016/j.immuni.2014.08.015 · Cited by 254
Izzo, F., Marra, P., Beneduce, G., Castello, G., Vallone, P., De Rosa, V., Cremona, F., Ensor, C. M., Holtsberg, F. W., Bomalaski, J. S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.120 · Cited by 250
The cytotoxic T cell proteome and its shaping by the kinase mTOR
Hukelmann, J. L., Anderson, K. E., Sinclair, L. V., Grzes, K. M., Murillo, A. B., Hawkins, P. T., Stephens, L. R., Lamond, A. I., & Cantrell, D. A. (2016) · Nature Immunology · doi:10.1038/ni.3314 · Cited by 249
Structure and Function of Cationic Amino Acid Transporters (CATs)
Closs, E. I., Boissel, J.-P., Habermeier, A., & Rotmann, A. (2006) · Journal of Membrane Biology · doi:10.1007/s00232-006-0875-7 · Cited by 249
Amino acid auxotrophy as a system of immunological control nodes
Murray, P. J. (2016) · Nature Immunology · doi:10.1038/ni.3323 · Cited by 249
Tapiero, H., Mathé, G., Couvreur, P., & Tew, K. D. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(02)00284-6 · Cited by 249
Decker, W. K., da Silva, R. F., Sanabria, M. H., Angelo, L. S., Guimarães, F., Burt, B. M., Kheradmand, F., & Paust, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00829 · Cited by 246
Ontogeny of Tumor-Associated Macrophages
Laviron, M., & Boissonnas, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01799 · Cited by 239
Ascierto, P. A., Scala, S., Castello, G., Daponte, A., Simeone, E., Ottaiano, A., Beneduce, G., De Rosa, V., Izzo, F., Melucci, M. T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0933 · Cited by 238
Gotoh, T., Sonoki, T., Nagasaki, A., Terada, K., Takiguchi, M., & Mori, M. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)01015-0 · Cited by 236
Rabinowich, H., Reichert, T. E., Kashii, Y., Gastman, B. R., Bell, M. C., & Whiteside, T. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1518 · Cited by 235
l-Arginine modulates CD3ζ expression and T cell function in activated human T lymphocytes
Zea, A. H., Rodriguez, P. C., Culotta, K. S., Hernandez, C. P., DeSalvo, J., Ochoa, J. B., Park, H.-J., Zabaleta, J., & Ochoa, A. C. (2004) · Cellular Immunology · doi:10.1016/j.cellimm.2005.01.004 · Cited by 233
Nakamura, K., Kassem, S., Cleynen, A., Chrétien, M.-L., Guillerey, C., Putz, E. M., Bald, T., Förster, I., Vuckovic, S., Hill, G. R., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.02.007 · Cited by 233
On the origin of myeloid-derived suppressor cells
Millrud, C. R., Bergenfelz, C., & Leandersson, K. (2017) · Oncotarget · doi:10.18632/oncotarget.12278 · Cited by 230
Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges
Phillips, M. M., Sheaff, M. T., & Szlosarek, P. W. (2013) · Cancer Research and Treatment · doi:10.4143/crt.2013.45.4.251 · Cited by 229
Pas de Deux: Control of Anti-tumor Immunity by Cancer-Associated Inflammation
Shalapour, S., & Karin, M. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.021 · Cited by 228
Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients
Wu, W.-C., Sun, H.-W., Chen, H.-T., Liang, J., Yu, X.-J., Wu, C., Wang, Z., & Zheng, L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320753111 · Cited by 227
The Pharmacodynamics of L-Arginine
Böger, R. H. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.6.1650s · Cited by 221
Cho, H., Seo, Y., Loke, K. M., Kim, S.-W., Oh, S.-M., Kim, J.-H., Soh, J., Kim, H. S., Lee, H., Kim, J., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0125 · Cited by 210
Plasma arginine and citrulline kinetics in adults given adequate and arginine-free diets.
Castillo, L., Chapman, T. E., Sanchez, M., Yu, Y. M., Burke, J. F., Ajami, A. M., Vogt, J., & Young, V. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7749 · Cited by 204
Thurlow, L. R., Joshi, G. S., Clark, J. R., Spontak, J. S., Neely, C. J., Maile, R., & Richardson, A. R. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2012.11.012 · Cited by 201
IL‐8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer
Rotondo, R., Barisione, G., Mastracci, L., Grossi, F., Orengo, A. M., Costa, R., Truini, M., Fabbi, M., Ferrini, S., & Barbieri, O. (2009) · International Journal of Cancer · doi:10.1002/ijc.24448 · Cited by 198
Sippel, T. R., White, J., Nag, K., Tsvankin, V., Klaassen, M., Kleinschmidt-DeMasters, B. K., & Waziri, A. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1107 · Cited by 195
Gray, M. J., Poljakovic, M., Kepka-Lenhart, D., & Morris, S. M. (2005) · Gene · doi:10.1016/j.gene.2005.04.004 · Cited by 191
Wu, H., Zhen, Y., Ma, Z., Li, H., Yu, J., Xu, Z.-G., Wang, X.-Y., Yi, H., & Yang, Y.-G. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aae0482 · Cited by 191
Suppression of in vitro cytotoxic response by macrophages due to induced arginase.
Kung, J. T., Brooks, S. B., Jakway, J. P., Leonard, L. L., & Talmage, D. W. (1977) · The Journal of experimental medicine · doi:10.1084/jem.146.3.665 · Cited by 188
Hossain, D. M. S., Pal, S. K., Moreira, D., Duttagupta, P., Zhang, Q., Won, H., Jones, J., D'Apuzzo, M., Forman, S., & Kortylewski, M. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3145 · Cited by 187
Tumor-Educated CD11bhighIalow Regulatory Dendritic Cells Suppress T Cell Response through Arginase I
Liu, Q., Zhang, C., Sun, A., Zheng, Y., Wang, L., & Cao, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803926 · Cited by 186
Kapanadze, T., Gamrekelashvili, J., Ma, C., Chan, C., Zhao, F., Hewitt, S., Zender, L., Kapoor, V., Felsher, D. W., Manns, M. P., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.06.010 · Cited by 185
MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis
Cook, R. S., Jacobsen, K. M., Wofford, A. M., DeRyckere, D., Stanford, J., Prieto, A. L., Redente, E., Sandahl, M., Hunter, D. M., Strunk, K. E., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67655 · Cited by 184
Cerutti, J. M., Delcelo, R., Amadei, M. J., Nakabashi, C., Maciel, R. M. B., Peterson, B., Shoemaker, J., & Riggins, G. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19617 · Cited by 184
Van Overmeire, E., Laoui, D., Keirsse, J., Van Ginderachter, J. A., & Sarukhan, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00127 · Cited by 180
“Of Mice and Menâ€: Arginine Metabolism in Macrophages
Thomas, A. C., & Mattila, J. T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00479 · Cited by 173
Yang, Q., Zheng, C., Cao, J., Cao, G., Shou, P., Lin, L., Velletri, T., Jiang, M., Chen, Q., Han, Y., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.71 · Cited by 172
Miret, J. J., Kirschmeier, P. T., Koyama, S., Zhu, M., Li, Y. Y., Naito, Y., Wu, M., Malladi, V. S., Huang, W., Walker, W., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0504-5 · Cited by 170
Brosnan, M. E., & Brosnan, J. T. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.10.2791s · Cited by 169
Mouse Model for Human Arginase Deficiency
Iyer, R. K., Yoo, P. K., Kern, R. M., Rozengurt, N., Tsoa, R., O'Brien, W. E., Yu, H., Grody, W. W., & Cederbaum, S. D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4491-4498.2002 · Cited by 168
Emerging Principles in Myelopoiesis at Homeostasis and during Infection and Inflammation
Schultze, J. L., Mass, E., & Schlitzer, A. (2019) · Immunity · doi:10.1016/j.immuni.2019.01.019 · Cited by 167
Jacobsen, L. C., Theilgaard‐Mönch, K., Christensen, E., & Borregaard, N. (2006) · Blood · doi:10.1182/blood-2006-06-032599 · Cited by 166
Sahin, E., Haubenwallner, S., Kuttke, M., Kollmann, I., Halfmann, A., Dohnal, A. M., Chen, L., Cheng, P. P., Hoesel, B., Einwallner, E., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302167 · Cited by 166
Yoon, C., Shim, Y., Kim, E., Lee, J., Won, N., Kim, J., Park, I., Yoon, D., & Min, B. (2007) · International Journal of Cancer · doi:10.1002/ijc.22322 · Cited by 165
Polyamine-Blocking Therapy Reverses Immunosuppression in the Tumor Microenvironment
Hayes, C. S., Shicora, A. C., Keough, M. P., Snook, A. E., Burns, M. R., & Gilmour, S. K. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0120-t · Cited by 165
Ming, X., Rajapakse, A. G., Yepuri, G., Xiong, Y., Carvas, J. M., Ruffieux, J., Scerri, I., Wu, Z., Popp, K., Li, J., et al. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.000992 · Cited by 165
Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy
Kropf, P., Baud, D., Marshall, S. E., Munder, M., Mosley, A., Fuentes, J. M., Bangham, C. R. M., Taylor, G. P., Herath, S., Choi, B., et al. (2007) · European Journal of Immunology · doi:10.1002/eji.200636542 · Cited by 164
Gielen, P. R., Schulte, B. M., Kers-Rebel, E. D., Verrijp, K., Bossman, S. A. J. F. H., ter Laan, M., Wesseling, P., & Adema, G. J. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now034 · Cited by 164
Mahadevan, N. R., Anufreichik, V., Rodvold, J. J., Chiu, K., Sepulveda, H., & Zanetti, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051845 · Cited by 163
Arginase Inhibitors: A Rational Approach Over One Century
Pudlo, M., Demougeot, C., & Girard, C. (2016) · Medicinal Research Reviews · doi:10.1002/med.21419 · Cited by 161
Ino, Y., Yamazaki–Itoh, R., Oguro, S., Shimada, K., Kosuge, T., Závada, J., Kanai, Y., & Hiraoka, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055146 · Cited by 160
Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency?
Vissers, Y. L. J., Dejong, C. H. C., Luiking, Y. C., Fearon, K. C. H., MEYENFELDT, M. F. V., & Deutz, N. E. P. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.5.1142 · Cited by 160
Kim, N. N., Cox, J. D., Baggio, R. F., Emig, F. A., Mistry, S. K., Harper, S. L., Speicher, D. W., Morris, Ash, D. E., Traish, A., et al. (2001) · Biochemistry · doi:10.1021/bi002317h · Cited by 158
Arginine metabolism and deprivation in cancer therapy
Zou, S., Wang, X., Liu, P., Ke, C., & Xu, S. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109210 · Cited by 158
Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer
El-Kenawi, A., Gatenbee, C., Robertson‐Tessi, M., Bravo, R., Dhillon, J., Balagurunathan, Y., Berglund, A., Vishvakarma, N. K., Ibrahim‐Hashim, A., Choi, J. W., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0542-2 · Cited by 156
Amino Acids License Kinase mTORC1 Activity and Treg Cell Function via Small G Proteins Rag and Rheb
Shi, H., Chapman, N. M., Wen, J., Guy, C. S., Long, L., Dhungana, Y., Rankin, S. L., Pelletier, S. W., Vogel, P., Wang, H., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.10.001 · Cited by 154
Regulation of NK Cell Function by Human Granulocyte Arginase
Oberlies, J., Watzl, C., Giese, T., Luckner, C., Kropf, P., Müller, I., Ho, A. D., & Munder, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803523 · Cited by 153
Baydoun, A. R., Emery, P. W., Pearson, J. D., & Mann, G. E. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80876-9 · Cited by 152
Si, Y., Merz, S. F., Jansen, P., Wang, B.-X., Bruderek, K., Altenhoff, P., Mattheis, S., Lang, S., Gunzer, M., Klode, J., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aaw9159 · Cited by 150
The functional role of polyamines in eukaryotic cells
Igarashi, K., & Kashiwagi, K. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.12.012 · Cited by 149
Rotondo, R., Bertolotto, M. B., Barisione, G., Astigiano, S., Mandruzzato, S., Ottonello, L. C., Dallegri, F., Bronte, V., Ferrini, S., & Barbieri, O. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1109737 · Cited by 148
Myeloid-Derived Suppressor Cells and anti-tumor T cells: a complex relationship
Monu, N. R., & Frey, A. B. (2012) · Immunological Investigations · doi:10.3109/08820139.2012.673191 · Cited by 144
Transcriptional Profiling Reveals Complex Regulation of the Monocyte IL-1β System by IL-13
Scotton, C. J., Martínez, F. O., Smelt, M. J., Sironi, M., Locati, M., Mantovani, A., & Sozzani, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.834 · Cited by 143
Molecular cloning and nucleotide sequence of cDNA for human liver arginase.
Haraguchi, Y., Takiguchi, M., Amaya, Y., Kawamoto, S., Matsuda, I., & Mori, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.2.412 · Cited by 143
Shi, O., Morris, S. M., Zoghbi, H. Y., Porter, C. W., & O’Brien, W. E. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.811-813.2001 · Cited by 143
Arginase I Induction during Leishmania major Infection Mediates the Development of Disease
Iniesta, V., Carcelén, J., Molano, I., Peixoto, P. M. V., Redondo, E., Parra, P., Mangas, M., Monroy, I., Campo, M. L., Nieto, C. G., et al. (2005) · Infection and Immunity · doi:10.1128/iai.73.9.6085-6090.2005 · Cited by 140
Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion
Talmadge, J. E., Hood, K. C., Zobel, L., Shafer, L. R., Coles, M., & Tóth, B. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.09.021 · Cited by 139
Cancer-promoting mechanisms of tumor-associated neutrophils
Hurt, B., Schulick, R. D., Edil, B. H., Kasmi, K. C. E., & Barnett, C. C. (2017) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2017.08.003 · Cited by 137
Schleicher, U., Paduch, K., Debus, A., Obermeyer, S., König, T., Kling, J. C., Ribechini, E., Dudziak, D., Mougiakakos, D., Murray, P. J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.001 · Cited by 136 · cited 1×
“Crucial role of ARG in the regulation of immune response by impairing NO production was also described in the model of cutaneous contact hypersensitivity (295) as well as in immune response to Leishmania major infections (296).”
BackgroundAltered functions of natural killer cells in response to L-Arginine availability
Lamas, B., Vergnaud, J., Gonçalves-Mendes, N., Perche, O., Rossary, A., Vasson, M., & Farges, M. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.11.018 · Cited by 136
Hyperargininemia due to liver arginase deficiency
Crombez, E. A., & Cederbaum, S. D. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.11.004 · Cited by 135
Ochocki, J. D., Khare, S., Hess, M., Ackerman, D., Qiu, B., Daisak, J. I., Worth, A. J., Lin, N., Lee, P., Xie, H. J., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.009 · Cited by 134
Role of arginine in superficial wound healing in man
Debats, I. B. J. G., Wolfs, T. G. A. M., Gotoh, T., Cleutjens, J. P. M., Peutz‐Kootstra, C. J., & van der Hulst, R. R. W. J. (2009) · Nitric Oxide · doi:10.1016/j.niox.2009.07.006 · Cited by 133
Lindgren, J. K., Thomas, V. C., Olson, M. S., Chaudhari, S. S., Nuxoll, A. S., Schaeffer, C. R., Lindgren, K. E., Jones, J., Zimmerman, M. C., Dunman, P. M., et al. (2014) · Journal of Bacteriology · doi:10.1128/jb.00051-14 · Cited by 130
Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy
Messmer, M. N., Netherby, C. S., Banik, D., & Abrams, S. I. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1639-3 · Cited by 127
Zhao, F., Obermann, S., von Wasielewski, R., Haile, L. A., Manns, M. P., Korangy, F., & Greten, T. F. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03105.x · Cited by 126
Arginase I Suppresses IL-12/IL-23p40–Driven Intestinal Inflammation during Acute Schistosomiasis
Herbert, D. R., Orekov, T., Roloson, A., Ilies, M., Perkins, C. L., O’Brien, W. E., Cederbaum, S. D., Christianson, D. W., Zimmermann, N., Rothenberg, M. E., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902009 · Cited by 126
Zabaleta, J., McGee, D. J., Zea, A. H., Hernández, C. P., Rodríguez, P. C., Sierra, R. A., Correa, P., & Ochoa, A. C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.586 · Cited by 125
Cao, Y. Q., Feng, Y., Zhang, Y., Zhu, X., & Jin, F. (2016) · BMC Cancer · doi:10.1186/s12885-016-2376-0 · Cited by 125
Wang, Y., Tian, J., Tang, X., Rui, K., Tian, X., Ma, J., Ma, B., Xu, H., Lu, L., & Wang, S. (2016) · Oncotarget · doi:10.18632/oncotarget.7324 · Cited by 122
Bozkus, C. C., Elzey, B. D., Crist, S. A., Ellies, L. G., & Ratliff, T. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500959 · Cited by 121
Nan, J., Xing, Y., Hu, B., Tang, J., Dong, H., He, Y., Ruan, D., Ye, Q., Cai, J., Ma, X., et al. (2017) · Immunology · doi:10.1111/imm.12876 · Cited by 121
Bron, L. P., Jandus, C., Andrejevic‐Blant, S., Speiser, D. E., Monnier, P., Romero, P. J., & Rivals, J. (2012) · International Journal of Cancer · doi:10.1002/ijc.27728 · Cited by 119
L-Arginine regulates the expression of the T-cell receptor zeta chain (CD3zeta) in Jurkat cells.
Taheri, F., Ochoa, J. B., Faghiri, Z., Culotta, K., Park, H. J., Lan, M. S., Zea, A. H., & Ochoa, A. C. (2001) · PubMed · Cited by 119
Ginderachter, J. A. V., Meerschaut, S., Liu, Y., Brys, L., Groeve, K. D., Ghassabeh, G. H., Raes, G., & BAETSELIER, P. D. (2006) · Blood · doi:10.1182/blood-2005-09-3777 · Cited by 119
Regulatory T cells use arginase 2 to enhance their metabolic fitness in tissues
Lowe, M. M., Boothby, I. C., Clancy, S., Ahn, R. S., Liao, W. J., Nguyen, D. N., Schumann, K., Marson, A., Mahuron, K. M., Kingsbury, G. A., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.129756 · Cited by 117
Modolell, M., Choi, B., Ryan, R. O., Hancock, M., Titus, R. G., Abebe, T., Hailu, A., Müller, I., Rogers, M. E., Bangham, C. R. M., et al. (2009) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000480 · Cited by 116
Pharmacokinetics of intravenous and oral L‐arginine in normal volunteers
Tangphao, O., Grossmann‡, M., Chalon, S., Hoffman, B. B., & Blaschke, T. F. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00883.x · Cited by 115
Shore, A. C., Rossney, A. S., Brennan, O. M., Kinnevey, P. M., Humphreys, H., Sullivan, D. J., Goering, R. V., Ehricht, R., Monecke, S., & Coleman, D. C. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01756-10 · Cited by 115
Cited by
Macrophages in immunoregulation and therapeutics
Chen, S., Saeed, A. F. U. H., Liu, Q., Jiang, Q., Xu, H., Xiao, G. G., Rao, L., & Duo, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01452-1 · Cited by 2,229
Metabolic barriers to cancer immunotherapy
DePeaux, K., & Delgoffe, G. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00541-y · Cited by 597
Interferon-γ: teammate or opponent in the tumour microenvironment?
Gocher, A. M., Workman, C. J., & Vignali, D. A. A. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00566-3 · Cited by 582
Myeloid-derived suppressor cells in cancer and cancer therapy
Lasser, S. A., Ozbay Kurt, F. G., Arkhypov, I., Utikal, J., & Umansky, V. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00846-y · Cited by 489
Arginine-dependent immune responses
Martí i Líndez, A.-A., & Reith, W. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03828-4 · Cited by 354
Metadata
- Authors
- Grzywa, T. M., Sosnowska, A., Matryba, P., Rydzynska, Z., Jasinski, M., Nowis, D., & Golab, J.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-05-15
- Volume
- 11
- Pages
- 938-938
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3024126283
- Cited by
- 424
- References
- 283
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.